Form 4: Ardent Health Partners CFO Reports Stock Transactions

Alfred Lumsdaine, CFO of Ardent Health Partners, reports the acquisition and disposal of company stock, including shares withheld for tax payments and the vesting of restricted stock units.

Summary

• Alfred Lumsdaine, the Chief Financial Officer of Ardent Health Partners, filed a Form 4 detailing changes in beneficial ownership of the company's stock.
• On March 31, 2025, 2,510 shares of common stock were disposed of to cover tax obligations at a price of $13.75 per share.
• On April 1, 2025, Mr. Lumsdaine acquired 53,971 shares of restricted stock units.
• These restricted stock units vest in three equal installments annually, starting April 1, 2025, contingent upon continued service with Ardent Health Partners.
• Following these transactions, Mr. Lumsdaine beneficially owns 214,536 shares of Ardent Health Partners stock.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.

Future Outlook

The restricted stock units vest in three substantially equal installments on each anniversary of April 1, 2025, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track management's alignment with shareholder interests.

Stakeholder Impact

• Shareholders can monitor insider transactions to assess management's confidence in the company's prospects.

Key Dates

Keywords

Form 4, Ardent Health Partners, Stock Transactions, Beneficial Ownership, CFO, Lumsdaine, Restricted Stock Units